Cranberries (Vaccinium macrocarpon) and Cardiovascular Disease Risk Factors

Authors: McKay, Diane L.; Blumberg, Jeffrey B.

Source: Nutrition Reviews, Volume 65, Number 11, November 2007 , pp. 490-502(13)

Publisher: International Life Sciences Institute

Buy & download fulltext article:

Price: $37.00 plus tax (Refund Policy)

Abstract:

The American cranberry (Vaccinium macrocarpon) is one of the three commercially important fruits native to North America. Cranberries are a particularly rich source of phenolic phytochemicals, including phenolic acids (benzoic, hydroxycinnamic, and ellagic acids) and flavonoids (anthocyanins, flavonols, and flavan-3-ols). A growing body of evidence suggests that polyphenols, including those found in cranberries, may contribute to reducing the risk of cardiovascular disease (CVD) by increasing the resistance of LDL to oxidation, inhibiting platelet aggregation, reducing blood pressure, and via other anti-thrombotic and anti-inflammatory mechanisms. Research regarding the bioactivity of cranberries and their constituents on risk factors for CVD is reviewed.

Keywords: CRANBERRY; VACCINIUM MACROCARPON; FLAVONOID; PROANTHOCYANIDIN; CARDIOVASCULAR DISEASE

Document Type: Research article

DOI: http://dx.doi.org/10.1301/nr.2007.nov.490-502

Publication date: 2007-11-01

More about this publication?

This journal is now published by Blackwell Publishing. Current issues of this journal are available here. Backfile content is in the process of being reloaded by Blackwell and will shortly be removed from this page and available only from the Blackwell link above.
Information for Authors
Subscribe to this Title
Translation Request
ingentaconnect is not responsible for the content or availability of external websites